-

NYSE: PACS ALERT: Investors in PACS Group, Inc. (NYSE: PACS) Shares Should Contact the Shareholders Foundation Regarding Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announces that a lawsuit is pending on behalf of certain investors in PACS Group, Inc. (NYSE: PACS) in the U.S. District Court for the Southern District of New York (Case No. 24-cv-08636).

NOTICE: Investors who purchased PACS Group, Inc. (NYSE: PACS) shares before April 2024 and continue to hold any of those shares may have certain legal options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1 (858) 779-1554.

On November 13, 2024, an investor filed a lawsuit against PACS Group, Inc. alleging violations of securities laws. The complaint alleges that the defendants failed to disclose to investors that the company had engaged in a scheme to submit false Medicare claims that allegedly accounted for more than 100% of PACS' operating and net income from 2020 through 2023; that the company had allegedly billed Medicare for thousands of unnecessary respiratory and sensory integration therapies; and that the company had allegedly falsified documentation relating to licensure and staffing.

The complaint further alleges that, as a result of these alleged practices, the defendants' positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On December 19, 2025, a consolidated amended complaint was filed. On February 17, 2026, the defendants filed a motion to dismiss the case.

Investors who purchased PACS Group, Inc. (NYSE: PACS) shares should contact the Shareholders Foundation, Inc. to learn more about their potential options.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Contacts

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

Shareholders Foundation, Inc.

NYSE:PACS
Details

Release Versions

Contacts

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

More News From Shareholders Foundation, Inc.

Long-Term CoreWeave, Inc. (NASDAQ: CRWV) Shareholders Should Contact the Shareholders Foundation Regarding Pending Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announces that a lawsuit is pending against CoreWeave, Inc. (NASDAQ: CRWV) in the U.S. District Court for the District of New Jersey (Case No. 2:26-cv-00355). NOTICE: Investors who purchased CoreWeave, Inc. (NASDAQ: CRWV) shares before March 28, 2025, and continue to hold any of those shares may have certain legal options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1 (858) 779-1554. On J...

LAWSUIT ALERT: Investors Who Lost Over $100,000 With ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Shares - Purchased Between March and June 2026 - Should Contact the Shareholders Foundation

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announces that a deadline is coming up on October 05, 2026, in the lawsuit that was filed for certain investors in ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) in the U.S. District Court for Southern District of California (No: 3:26-cv-04469). Investors, who purchased shares in excess of $100,000 of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, have certain options and there are short and strict deadli...

LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation

SAN DIEGO--(BUSINESS WIRE)--The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares in the U.S. District Court for the Northern District of California (No: 5:26-cv-07691). Investors, who purchased shares of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) have certain options. NASDAQ: PRCT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On...
Back to Newsroom